Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in CADL — Candel Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,873,123
+$2,640,854 QoQ
Shares Held
278,944
+488.5% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 138 holders
Holding Since
Dec 2021
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. CADL ranks #172 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in CADL

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,873,123 278,944
2026-03-31 $232,269 47,402
2025-12-31 $289,742 51,282
2025-09-30 $242,978 47,643
2025-06-30 $370,001 73,123
2025-03-31 $1,012,767 179,251
2024-12-31 $579,918 66,811
2024-09-30 $151,482 21,859
2024-06-30 $337,583 54,449
2023-12-31 $26 18
2022-12-31 $38 22
2022-09-30 $646 206
2022-06-30 $485 150
2022-03-31 $7,440 1,462
2021-12-31 $8,508 1,088